Healthcare costs and utilization for patients age 50-64 years with acute myeloid leukemia treated with chemotherapy or with chemotherapy and allogeneic hematopoietic cell transplantation

The primary aim of this study was to describe healthcare costs and utilization during the first year after a diagnosis of acute myeloid leukemia (AML) for privately insured non-Medicare patients in the United States (US) aged 50-64 years who were treated with either chemotherapy or chemotherapy and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Preussler, Jaime M., Meyer, Christa L., Mau, Lih-Wen, Majhail, Navneet S., Denzen, Ellen, Edsall, Kristen C., Farnia, Stephanie H., Saber, Wael, Burns, Linda J., Vanness, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497312/
https://ncbi.nlm.nih.gov/pubmed/28263920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.02.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados